Sedana Medical AB (publ)
SSE:SEDANA.ST
16.85 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 153.867 | 122.865 | 159.152 | 141.77 | 71.646 | 57.896 | 40.428 | 32.155 | 28.113 |
| Cost of Revenue
| 44.886 | 36.791 | 52.446 | 52.867 | 19.232 | 15 | 9.475 | 9.228 | 10.264 |
| Gross Profit
| 108.981 | 86.074 | 106.706 | 88.903 | 52.413 | 42.897 | 30.953 | 22.927 | 17.849 |
| Gross Profit Ratio
| 0.708 | 0.701 | 0.67 | 0.627 | 0.732 | 0.741 | 0.766 | 0.713 | 0.635 |
| Reseach & Development Expenses
| 20.805 | 19.944 | 19.704 | 7.859 | 7.347 | 0.362 | 0.282 | 0 | 0 |
| General & Administrative Expenses
| 47.504 | 57.473 | 51.736 | 37.296 | 27.122 | 21.651 | 16.825 | 10.606 | 10.43 |
| Selling & Marketing Expenses
| 107.239 | 112.469 | 96.573 | 65.123 | 37.326 | 0 | 0 | 0 | 0 |
| SG&A
| 154.743 | 169.942 | 148.309 | 102.419 | 27.122 | 21.651 | 16.825 | 10.606 | 10.43 |
| Other Expenses
| -0.015 | 0.122 | -0.11 | 0.166 | 42.017 | 29.789 | 17.747 | 11.702 | 8.806 |
| Operating Expenses
| 175.548 | 190.008 | 167.903 | 110.444 | 69.14 | 51.44 | 34.573 | 22.308 | 19.236 |
| Operating Income
| -66.567 | -103.934 | -61.197 | -21.541 | -16.727 | -8.238 | -3.488 | 0.618 | -1.387 |
| Operating Income Ratio
| -0.433 | -0.846 | -0.385 | -0.152 | -0.233 | -0.142 | -0.086 | 0.019 | -0.049 |
| Total Other Income Expenses Net
| 7.548 | 31.001 | 3.826 | -2.563 | -0.217 | 2.024 | -0.981 | 0.018 | 0.194 |
| Income Before Tax
| -59.019 | -72.933 | -57.371 | -24.104 | -16.943 | -6.52 | -4.601 | 0.637 | -1.193 |
| Income Before Tax Ratio
| -0.384 | -0.594 | -0.36 | -0.17 | -0.236 | -0.113 | -0.114 | 0.02 | -0.042 |
| Income Tax Expense
| 0.593 | 0.574 | 0.595 | 3.035 | -0.586 | 0.349 | -0.726 | -0.649 | 0.012 |
| Net Income
| -59.612 | -73.507 | -57.966 | -27.139 | -16.358 | -6.869 | -3.876 | 1.286 | -1.205 |
| Net Income Ratio
| -0.387 | -0.598 | -0.364 | -0.191 | -0.228 | -0.119 | -0.096 | 0.04 | -0.043 |
| EPS
| -0.6 | -0.74 | -0.62 | -0.3 | -0.2 | -0.09 | -0.057 | 0.019 | -0.018 |
| EPS Diluted
| -0.6 | -0.74 | -0.62 | -0.3 | -0.2 | -0.09 | -0.057 | 0.019 | -0.018 |
| EBITDA
| -59.437 | -48.777 | -43.801 | -9.439 | -11.378 | -0.854 | -0.013 | 3.034 | 0.163 |
| EBITDA Ratio
| -0.386 | -0.397 | -0.275 | -0.067 | -0.159 | -0.015 | -0 | 0.094 | 0.006 |